Healthcare & Life Sciences Partner Michael Werner will speak at the BIO International Convention on a panel titled, "Bioethics: Synonymous With Good Business."
Biotechnology and its applications often raise controversial bioethics issues. Over the years, companies have developed internal and external strategies for addressing these issues responsibly. These strategies make good business sense; companies that adopt policies of transparency and responsibility have been able to thrive as science has advanced. In this session, leading companies will describe their process and policies and provide recommendations to others in industry who are looking for successful approaches.
Please note that email communications to the firm through this website do not create an attorney-client relationship between you and the firm. Do not send any privileged or confidential information to the firm through this website. Click "accept" below to confirm that you have read and understand this notice.